Adhera Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Adhera Therapeutics generated cash of -$1,415,000, which is less than the previous year. Cash used in financing activities reached the amount of $1,371,000 last year. Net change in cash is therefore -$44,000.
Cash Flow
| 2013 | 285K | 410K | -2K |
|---|---|---|---|
| 2014 | -4.77M | 0 | 5.69M |
| 2015 | -2.16M | -45K | 1.09M |
| 2016 | -522.31K | 5.86K | 359.94K |
| 2017 | -1.26M | -375K | 1.63M |
| 2018 | -9.61M | -74.36K | 13.49M |
| 2019 | -8.73M | 0 | 4.87M |
| 2020 | -588K | 0 | 539K |
| 2021 | -665K | 0 | 739K |
| 2022 | -1.41M | 0 | 1.37M |
ATRX Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 76K | 1K | 50K | 3.91M | 106.37K | 105.34K | 261.84K | 1.82M | 909K | 216K |
Operating activities | ||||||||||
Net income | -2.11M | -6.35M | -3.76M | -11.97M | -16.75M | -6.21M | -837.14K | 3.33M | -6.47M | -1.57M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 398K | 400K | 82K | 332.98K | 450.90K | 49.18K | 0 | 0 | 2.00M |
Stock-based compensation expense | 0 | 0 | 8K | 765K | 0 | 424.78K | 36 | 504K | 277K | 135K |
| Deferred income tax benefit | 0 | 0 | 8K | 765K | 0 | 424.78K | 36 | 504K | 277K | 135K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 120K | 0 | 16K | -116.36K | 0 | 0 | 500K | -495K | 2K |
Inventories | 0 | -120K | 0 | -240K | -204.36K | 0 | 0 | 0 | 0 | 620K |
Accounts payable | 68K | 94K | 854K | 1.13M | -703.15K | 425.33K | -876.04K | 94K | -563K | 8K |
Cash generated by operating activities | -1.41M | -665K | -588K | -8.73M | -9.61M | -1.26M | -522.31K | -2.16M | -4.77M | 285K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | -74.36K | -375K | 0 | -45K | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 5.86K | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | -74.36K | -375K | 5.86K | -45K | 0 | 410K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 116K | 23K | 4K | 13.89M | 250K | 3.67M | 1M | 3.51M | 0 |
Payments for dividends | 0 | 0 | 0 | -1.50M | 0 | 0 | 0 | -690K | 0 | 0 |
Repurchases of common stock | -2K | -739K | -539K | -100K | -250K | 0 | 0 | 0 | 8.43M | 0 |
Repayments of term debt | 1.71M | -739K | -539K | 0 | -143.83K | 1.26M | -359.94K | 0 | -250K | 0 |
Cash used in financing activities | 1.37M | 739K | 539K | 4.87M | 13.49M | 1.63M | 359.94K | 1.09M | 5.69M | -2K |
Net Change In Cash | -44K | 74K | -49K | -3.86M | 3.81M | 1.03K | -156.50K | -1.11M | 915K | 693K |
Cash at end of period | 32K | 75K | 1K | 50K | 3.91M | 106.37K | 105.34K | 710K | 1.82M | 909K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |